Act Two of PARADIGM-HF Not a Show-Stopper

November 17, 2014 10:44 PM

13 0

CHICAGO -- In addition to a mortality benefit already reported, the investigational heart failure drug LCZ696 appears to reduce a wide range of heart failure disabilities and symptoms, suggesting that patients may "feel" better when taking the drug.

But at least one heart failure expert is warning that mining these data may be hazardous.

Read more

To category page